title: Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers.
abstract: We have previously reported increased expression of matrix metalloproteinase-2 (MMP-2) using a rat model of liver fibrosis. However we did not clarify how the precursor of MMP-2 (proMMP-2) was activated. Therefore, we used human liver specimens with chronic hepatitis (CH) and liver cirrhosis (LC) to examine expression of membrane-type-1-MMP (MT1-MMP), which has recently been determined to activate proMMP-2. Northern hybridization studies showed a 5.4- and 1.4-fold increase in MMP-2 expression in CH and LC, respectively, as compared with normal liver. MT1-MMP gene expression simultaneously increased 4.0- and 1.4-fold in CH and LC, respectively. In situ hybridization using 35S-cRNA probes of MMP-2 and MT1-MMP showed prominent silver granules in elongated cells found in the lobules, periportal areas, and fibrous septa of CH and LC samples. These elongated cells expressed alpha-smooth muscle actin by immunohistochemistry. Immunoelectron microscopic examination localized MMP-2 and MT1-MMP to the rough endoplasmic reticulum of stellate cells located in the lobules and periportal areas, or to fibroblasts in the fibrous septa, suggesting that MMP-2 and MT1-MMP were produced by these cells. In addition, cytoplasmic and membranous immunodeposits of both MMPs were found in endothelial cells, Kupffer cells, capillary endothelial cells, and lymphocytes, indicating that activation of proMMP-2 occurs locally. Increased expression of MMP-2 and MT1-MMP was detected in CH and LC, while dual over-expression was found in stellate cells and fibroblasts, possibly resulting in the increase of active MMP-2 in and around these cells. These findings suggest that activated MMP-2 may remodel liver parenchyma during the process of liver fibrosis.
authors.affiliation: Third Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Takahara
authors.forename: K
authors.initials: K
authors.lastname: Furui
authors.forename: Y
authors.initials: Y
authors.lastname: Yata
authors.forename: B
authors.initials: B
authors.lastname: Jin
authors.forename: L P
authors.initials: LP
authors.lastname: Zhang
authors.forename: S
authors.initials: S
authors.lastname: Nambu
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Seiki
authors.forename: A
authors.initials: A
authors.lastname: Watanabe
mesh_terms: D000328:Adult; D000368:Aged; D015152:Blotting, Northern; D018870:Endoplasmic Reticulum, Rough / Q000201:enzymology / Q000648:ultrastructure; D005260:Female; D018093:Gelatinases / Q000378:metabolism*; D006521:Hepatitis, Chronic / Q000201:enzymology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008099:Liver / Q000201:enzymology / Q000648:ultrastructure; D008103:Liver Cirrhosis / Q000201:enzymology* / Q000473:pathology; D008297:Male; D020778:Matrix Metalloproteinase 2; D053504:Matrix Metalloproteinases, Membrane-Associated; D008666:Metalloendopeptidases / Q000378:metabolism*; D016253:Microscopy, Immunoelectron; D008875:Middle Aged; D012313:RNA / Q000032:analysis
chemical_list: D012313:RNA; D018093:Gelatinases; D053504:Matrix Metalloproteinases, Membrane-Associated; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2